AstraZeneca Current Affairs - 2020

Russia to sell COVID-19 vaccines to India

On September 16, 2020, Russia’s sovereign wealth fund agreed to supply 100 million doses of COVID-19 vaccine, Sputnik-V to an Indian drug company Dr Reddy’s Laboratories. The deal has been finalized after the Russian Direct Investment Fund (RDIF) reached agreements with the Indian manufacturer to produce 300 million doses of COVID-19 vaccines to India. What Read More…

Oxford vaccine to resume trial in the UK

The clinical trials of AstraZeneca vaccine were halted recently due to some safety reasons in the United Kingdom when one of the volunteers reported unexplained illness in his body after taking the vaccine. After the safety review, the Oxford and his partner drug company said in a separate statement that the clinical trial will resume. Read More…

SII directed to suspend recruitment for Oxford vaccine trial

Drugs Controller General of India (DCGI) which is country’s apex drug regulator has directed Serum Institute of India SII to suspend the new recruitments which were about to happen for recent phase 2 and 3 clinical trials of the Oxford COVID-19 vaccine till further orders. Why the SII is asked to suspend recruitment for vaccine Read More…